Media formats available:
Recommended
- SGLT2 inhibition in CKD: Discussing the key questions & evidenceOutcomes of SGLT2i in Diabetic Kidney Disease: Is it all diabetes?
Mark Cooper, MD
- SGLT2 inhibition in CKD: Discussing the key questions & evidenceThe clinical landscape of managing patients with CKD
Prof. David Cherney